Walleye Capital LLC Neuronetics, Inc. Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.74 - $6.87 $7,767 - $19,476	-2,835 Reduced 7.83%	33,379 $229,000
Q3 2022 Nov 14, 2022	BUY	$2.35 - $4.66 $85,102 - $168,757	36,214 New	36,214 $115,000
Q1 2022 May 16, 2022	SELL	$2.84 - $4.52 $28,990 - $46,140	-10,208 Closed	0 $0
Q4 2021 Mar 03, 2022	SELL	$3.87 - $6.59 $81,622 - $138,989	-21,091 Reduced 67.39%	10,208 $45,000
Q3 2021 Nov 15, 2021	BUY	$6.22 - $15.54 $194,679 - $486,386	31,299 New	31,299 $205,000
Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.61 $20,870 - $38,633	-14,802 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.28 - $4.5 $32,719 - $115,029	-25,562 Reduced 63.33%	14,802 $28,000
Q4 2019 Feb 14, 2020	BUY	$4.03 - $9.22 $162,666 - $372,156	40,364 New	40,364 $181,000

18.3M

3.8K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $20.5M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.